The 2018 assisi think tank meeting on breast cancer: International expert panel white paper

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  • Meritxell Arenas, University Hospital Sant Joan de Reus
  • ,
  • Ugur Selek, Koc University
  • ,
  • Orit Kaidar-Person, Rambam Medical Center
  • ,
  • Elisabetta Perrucci, Perugia General Hospital
  • ,
  • Angel Montero Luis, University Hospital HM Sanchinarro
  • ,
  • Liesbeth Boersma, Maastricht University
  • ,
  • Charlotte Coles, Cambridge University Hospitals NHS Foundation Trust
  • ,
  • Birgitte Offersen
  • Icro Meattini, Azienda Ospedaliera Careggi
  • ,
  • Yasemin Bölükbaşı, Koc University
  • ,
  • Maria Cristina Leonardi, IRCCS Istituto Europeo di Oncologia - Milano
  • ,
  • Raphael Pfeffer, Assuta Medical Centres, Tel Aviv, Israel. Electronic address: raphipf@013net.net.
  • ,
  • Bruno Cutuli, Institut du Cancer Courlancy
  • ,
  • Cristiana Vidali, University of Trieste
  • ,
  • Pierfrancesco Franco, University of Turin
  • ,
  • Vassilis Kouloulias, University of Athens
  • ,
  • Valeria Masiello, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
  • ,
  • Sofia Rivera, Institut Gustave Roussy
  • ,
  • Céline Bourgier, Universite de Montpellier
  • ,
  • Antonella Ciabattoni, San Filippo Neri Hospital
  • ,
  • Valentina Lancellotta, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
  • ,
  • Lurdes Trigo, Instituto Portugues de Oncologia de Francisco Gentil Porto
  • ,
  • Vincenzo Valentini, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
  • ,
  • Philip Poortmans, University of Antwerp
  • ,
  • Cynthia Aristei, University of Perugia

We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.

Original languageEnglish
Article number102967
JournalCritical Reviews in Oncology/Hematology
Volume151
ISSN1040-8428
DOIs
Publication statusPublished - Jul 2020

    Research areas

  • Breast cancer, Breast reconstruction, De-escalating therapy, Ductal carcinoma in situ, Hypofractionation, Neoadjuvant chemotherapy, Partial breast irradiation, Post-mastectomy radiation therapy, Radiation therapy

See relations at Aarhus University Citationformats

ID: 189386307